Medikamente zur Behandlung von Persönlichkeits- und Verhaltensstörungen

Benkert, Otto; Hippius, Hanns

doi:10.1007/978-3-642-29810-3_11

Otto Benkert³ &
Hanns Hippius⁴

3473 Accesses

Zusammenfassung

Definition, Abgrenzung und Klassifikation dieser Störungen (Achse-II-Störungen in multidimensionalen Diagnosesystemen) sind nicht abgeschlossen; auch der Begriff Persönlichkeitsstörung ist umstritten. Neben der kategorialen Einteilung wurde immer eine dimensionale Sichtweise gefordert, in DSM-V wird ein Hybridmodell mit kategorialen und dimensionalen Anteilen implementiert und der Cluster/Prototypansatz zumindest wieder relativiert (Skodol et al. 2011).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Chapter: USD 29.95; Price excludes VAT (USA)

eBook: USD 44.99; Price excludes VAT (USA)

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Literatur

Barnicot K, Katsakou C, Marougka S, Priebe S (2011) Treatment completion in psychotherapy for borderline personality disorder: a systematic review and meta-analysis. Acta Psychiatr Scand 123: 327–338
Article PubMed CAS Google Scholar
Bevilacqua L, Carli V, Sarchiapone M et al (2012) Interaction between FKBP5 and childhood trauma and risk of aggressive behavior. Arch Gen Psychiatry 69: 62–70
Article PubMed CAS Google Scholar
Ingenhoven T, Lafay P, Rinne T et al (2010) Effectiveness of pharmacotherapy for severe personality disorders: meta-analyses of randomized controlled trials. J Clin Psychiatry 71: 14–25
Article PubMed CAS Google Scholar
Kliem S, Kröger C, Kosfelder J (2010) Dialectical behavior therapy for borderline personality disorder: a meta-analysis using mixed-effects modeling. J Consult Clin Psychol 78: 936–951
Article PubMed Google Scholar
Skodol AE, Bender DS, Morey LC et al (2011) Personality disorder types proposed for DSM-5. J Pers Disord 25: 136–169
Article PubMed Google Scholar
Stoffers J, Völlm BA, Rücker G et al (2010) Pharmacological interventions for borderline personality disorder. Cochrane Database Syst Rev 6: CD005653
PubMed Google Scholar
Vita A, De Peri L, Sacchetti E (2011) Antipsychotics, antidepressants, anticonvulsants, and placebo on the symptom dimensions of borderline personality disorder: a meta-analysis of rand- omized controlled and open-label trials. J Clin Psychopharmacol 31: 613–624
Article PubMed CAS Google Scholar
Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice G (2010) Time to attainment of recovery from borderline personality disorder and stability of recovery: A 10-year prospective follow-up study. Am J Psychiatry 167: 663–667
Article PubMed Google Scholar

Download references

Author information

Authors and Affiliations

Mainz
Prof. Dr. med. Otto Benkert
München
Prof. Dr. med. Hanns Hippius

Authors

Prof. Dr. med. Otto Benkert
View author publications
You can also search for this author in PubMed Google Scholar
Prof. Dr. med. Hanns Hippius
View author publications
You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

About this chapter

Cite this chapter

Benkert, O., Hippius, H. (2013). Medikamente zur Behandlung von Persönlichkeits- und Verhaltensstörungen. In: Kompendium der Psychiatrischen Pharmakotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-29810-3_11

Download citation

DOI: https://doi.org/10.1007/978-3-642-29810-3_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-29809-7
Online ISBN: 978-3-642-29810-3
eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics